Here's the live share price of MPS Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of MPS Pharma has gained 38.71% CAGR. Over the past year, the corresponding return has been -52.38%.
MPS Pharma’s current P/E of -4.06x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
MPS Pharma | 0 | -15.56 | -33.80 | -43.11 | -52.38 | 2.98 | 38.71 |
Sun Pharmaceutical Industries | 1.31 | -1.09 | -2.08 | -5.36 | -13.47 | 22.68 | 25.83 |
Divi's Laboratories | 0.83 | -1.39 | -6.98 | 7.25 | 11.48 | 18.88 | 13.62 |
Cipla | -0.56 | -0.60 | 3.42 | 4.15 | -6.95 | 14.54 | 15.64 |
Torrent Pharmaceuticals | -1.45 | -3.07 | 8.89 | 15.71 | 2.59 | 33.77 | 20.06 |
Dr. Reddy's Laboratories | 0.60 | 3.81 | -0.53 | 14.04 | -1.07 | 16.97 | 6.33 |
Mankind Pharma | -1.86 | 3.65 | 8.83 | 17.87 | 4.35 | 21.60 | 12.45 |
Zydus Lifesciences | -0.49 | 4.84 | 7.86 | 15.78 | -6.85 | 42.20 | 21.28 |
Lupin | 3.28 | 3.71 | 5.09 | 2.58 | -10.05 | 47.11 | 14.50 |
Abbott India | -0.56 | -4.62 | -2.15 | 3.14 | 7.79 | 21.42 | 13.61 |
Alkem Laboratories | 2.74 | 2.19 | 13.58 | 13.49 | -12.12 | 18.98 | 14.00 |
Aurobindo Pharma | 4.53 | 0.72 | -1.05 | -1.35 | -29.26 | 28.31 | 6.24 |
Glenmark Pharmaceuticals | -4.23 | 3.38 | 23.42 | 42.64 | 19.13 | 76.60 | 32.90 |
Laurus Labs | 0.34 | 3.98 | 36.20 | 54.74 | 79.48 | 21.03 | 26.20 |
Biocon | -2.25 | -2.32 | 0.91 | 6.54 | -5.26 | 7.04 | -4.25 |
Anthem Biosciences | 3.35 | 5.26 | 15.40 | 15.40 | 15.40 | 4.89 | 2.91 |
GlaxoSmithKline Pharmaceuticals | -2.51 | -0.97 | -15.06 | 2.60 | -1.34 | 25.10 | 9.40 |
Cohance Lifesciences | -0.70 | 9.33 | -0.98 | -13.46 | -14.96 | 28.80 | 20.69 |
Ipca Laboratories | -0.40 | -5.50 | -3.56 | -0.52 | -10.15 | 15.13 | 4.03 |
Gland Pharma | 3.84 | 0.24 | 13.15 | 27.25 | 7.01 | -4.16 | 1.66 |
Over the last one year, MPS Pharma has declined 52.38% compared to peers like Sun Pharmaceutical Industries (-13.47%), Divi's Laboratories (11.48%), Cipla (-6.95%). From a 5 year perspective, MPS Pharma has outperformed peers relative to Sun Pharmaceutical Industries (25.83%) and Divi's Laboratories (13.62%).
Day | SMA | EMA |
---|---|---|
5 | 2.07 | 2.07 |
10 | 2.29 | 2.25 |
20 | 2.53 | 2.52 |
50 | 3.3 | 2.94 |
100 | 3.2 | 2.93 |
200 | 2.36 | 2.59 |
In the latest quarter, MPS Pharma remained same as its previous close in promoter holding, while DII stake unchanged at 0.58%, FII holding unchanged at 0.00%, and public shareholding moved up to 63.53% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 09, 2025, 12:36 AM IST | MPS Pharma - Reg. 34 (1) Annual Report. |
Sep 06, 2025, 9:46 PM IST | MPS Pharma - Pursuant To Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015, Notice"r |
Sep 06, 2025, 12:07 AM IST | MPS Pharma - Submission Of Annual Report For The Financial Year 2024-2025 |
Sep 06, 2025, 12:03 AM IST | MPS Pharma - Submission Of Annual Report For The Financial Year 2024-2025 |
Sep 02, 2025, 10:50 PM IST | MPS Pharma - Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Read With Schedule III Of The SEBI |
MPS Pharma Ltd. is a Public Limited Listed company incorporated on 09/09/1994 and has its registered office in the State of Haryana, India. Company's Corporate Identification Number(CIN) is L74899HR1994PLC038300 and registration number is 038300. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 19.11 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for MPS Pharma is ₹1.90 as on Sep 15, 2025.
The MPS Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of MPS Pharma is ₹3.63 Cr as on Sep 15, 2025.
Today’s highest and lowest price of MPS Pharma are ₹2.00 and ₹1.90.
The 52-week high/low is the highest and lowest price at which MPS Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of MPS Pharma is ₹4.33 and 52-week low of MPS Pharma is ₹1.90 as on Sep 15, 2025.
The MPS Pharma has shown returns of -5.0% over the past day, -15.56% for the past month, -33.8% over 3 months, -52.38% over 1 year, 2.98% across 3 years, and 38.71% over 5 years.
P/E ratio of and PB ratio of MPS Pharma are -4.06 and 3.36 on Sep 15, 2025. While the company gives a dividend yield of 0.00 per annum.